BioHarvest Sciences Inc. (CSE:BHSC)
Canada · Delayed Price · Currency is CAD | Market Cap | 137.76M |
| Revenue (ttm) | 30.30M |
| Net Income (ttm) | -23.23M |
| Shares Out | 17.33M |
| EPS (ttm) | -1.51 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 300 |
| Average Volume | 461 |
| Open | 8.05 |
| Previous Close | 7.95 |
| Day's Range | 7.95 - 8.05 |
| 52-Week Range | 6.24 - 10.50 |
| Beta | 1.51 |
| RSI | 47.62 |
| Earnings Date | Mar 28, 2025 |
About BioHarvest Sciences
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness produc... [Read more]
Financial Performance
In 2023, BioHarvest Sciences's revenue was $12.67 million, an increase of 130.48% compared to the previous year's $5.50 million. Losses were -$12.56 million, 11.8% more than in 2022.
Financial numbers in USD Financial StatementsNews
BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles
Rehovot, Israel--(Newsfile Corp. - June 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound
First CDMO Project to Utilize In-house AI Tools for Discovery of Plant Cell Targets for the Botanical Synthesis Process Rehovot, Israel--(Newsfile Corp. - May 21, 2025) - BioHarvest Sciences Inc. (NAS...
BioHarvest Sciences: Investors Remain Unconvinced Post Q1 Earnings Release
BioHarvest Sciences leverages botanical synthesis technology for rapid growth in pharmaceuticals, nutraceuticals, cosmetics, and nutrition. Click here to read.
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings Call Transcript
BioHarvest Sciences Reports First Quarter 2025 Financial Results
First Quarter Revenues Grew 47% to $7.9 Million, Exceeding Management Guidance Rehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or t...
BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company
Successful Progression Validates Botanical Synthesis Platform for a Variety of Molecule Types Rehovot, Israel--(Newsfile Corp. - May 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("B...
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time
Rehovot, Israel--(Newsfile Corp. - May 1, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology ...
BioHarvest Sciences Inc (BHST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...
BioHarvest Sciences Inc (BHST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion
BioHarvest Sciences Inc. (BHST) Q4 2024 Earnings Conference Call Transcript
BioHarvest Sciences GAAP EPS of -$0.17 misses by $0.03, revenue of $7.3M beats by $0.06M
BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results
Fourth Quarter Revenues Grew 62% to $7.3 Million, Exceeding Prior Management Guidance, with Full Year Revenues Increasing 99% Year-Over-Year to $25.2 Million CDMO Division Secures Anchor Partnership w...
BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time
Rehovot, Israel--(Newsfile Corp. - March 17, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technolo...
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 6, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical...
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells
Non-Alcoholic Fatty Liver Disease (NAFLD) Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest's Future Olive Cell Product Targeting Liver Health Vancouver, British Columbia a...
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD
Commercial success of VINIA validates the power of BioHarvest's patented Botanical Synthesis technology to produce valuable plant-based Compounds at industrial scale Vancouver, British Columbia and Re...
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pione...
BioHarvest Announces Appointment of Sharon Malka to Board of Directors
Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the Board Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 22, 2025) - BioHarvest Sc...
BioHarvest Issues Shareholder Letter and Provides Corporate Update
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2025) - BioHarvest Sciences Inc. , (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pione...
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology
New collaboration to pioneer next generation of plant-based ingredients for healthier food and beverages London, United Kingdom and Vancouver, British Columbia--(Newsfile Corp. - December 11, 2024) - ...
BioHarvest Sciences Inc. (BHST) Q3 2024 Earnings Call Transcript
BioHarvest Sciences Inc. (NASDAQ:BHST) Q3 2024 Earnings Conference Call November 25, 2024 4:30 PM ET Company Participants Justin Meiklem - IR Ilan Sobel - CEO Bar Dichter - CFO Zaki Rakib - President...
BioHarvest Sciences Reports Third Quarter 2024 Financial Results
Third Quarter 2024 Revenue Increased 101% Year-over-Year to Over $6.5 Million, Exceeding Management Guidance Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - Bio...
BioHarvest Launches VINIA SuperFood Functional Tea Line
Incremental Product Launch Addresses $3.3 Billion North American Functional Tea Market Opportunity with First SuperFood Tea Infused with Piceid Resveratrol Vancouver, British Columbia and Rehovot, Isr...
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 21, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pione...
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 18, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company"), a company pionee...
BioHarvest Sciences Begins Trading on the Nasdaq Global Market
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 12, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) ("BioHarvest" or the "Company"), a company pioneering its pa...